Neurocrine Biosciences
The Sr. Principal Scientist, Pharmacometrics leads pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation efforts to drive clinical development for Neurocrine's small- and large-molecule programs. This role involves performing advanced quantitative analyses, overseeing external vendor work, and communicating strategic findings to cross-functional teams and regulatory bodies. The position requires deep expertise in modeling software and a strong background in clinical drug development to support INDs and NDAs.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
Right around the average for this role
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Associate Scientific Director, Pharmacometrics
lifelancer
Senior Clinical Pharmacologist
Regeneron Pharmaceuticals
Director, Clinical Pharmacology & Pharmacometrics
Xencor
Senior Advisor - PK/PD & Pharmacometrics Project Leader
Eli Lilly and Company
Senior Manager, Pharmacometrics, Clinical Pharmacology
Travere Therapeutics
Senior Specialist, Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology (QP2‑IO)
MSD